image credit: Unsplash

Viveve Announces FDA 510K Approval to Expand Manufacturing of Treatment Tips

December 3, 2020

Via: BioSpace

Viveve, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s intimate health, today announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) expanding manufacturing capacity for its consumable treatment tips used with the Company’s Cryogen-cooled Monopolar Radiofrequency (CMRF) technology. Expanded manufacturing capacity will help Viveve continually meet market demand while reducing manufacturing costs.

Read More on BioSpace